These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 6083912)

  • 21. [Factor VIII complex activities in acute leukemia].
    Pniejnia-Olszyński W; Lopaciuk S
    Acta Haematol Pol; 1980; 11(4):239-47. PubMed ID: 6794320
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Von Willebrand factor, diabetes mellitus and retinopathy.
    Paton RC; Passa P; Canivet J
    Horm Metab Res Suppl; 1981; 11():55-8. PubMed ID: 6797913
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Immunocytochemical localization of factor VIII-related antigen in blood vessels of the human central nervous system].
    Miyagami M; Tsubokawa T; Smith BH; Kornblith PL
    No To Shinkei; 1984 Aug; 36(8):755-65. PubMed ID: 6093836
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Altered serum factor VIII-related antigen (VIII : AGN)/von Willebrand factor (VIII : vWf) in haemophiliacs with inhibitors to factor VIII procoagulant activity (VIII : C).
    Ballard JO; Sanders JC; Eyster ME
    Thromb Haemost; 1981 Feb; 45(1):68-72. PubMed ID: 6166064
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The factor VIII complex in atherosclerosis].
    Marra R; De Stefano V; Pagano L; Bizzi B
    Minerva Med; 1982 Nov; 73(46):3273-81. PubMed ID: 6817235
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Changes in factor VIII complex activities during the production of a clinical intermediate purity factor VIII concentrate.
    Prowse CV; Griffin B; Pepper DS; Dickson AJ; McQuillan TA; Dickson IH; Foster PR
    Thromb Haemost; 1981 Oct; 46(3):597-601. PubMed ID: 6797090
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Alveolar rhabdomyosarcoma associated with disseminated intravascular coagulation and a unique factor VIII antigen.
    Butler WM; Scialla SJ; Taylor HG
    Arch Intern Med; 1982 Jul; 142(7):1379-80. PubMed ID: 6807236
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of proteases in AHF concentrates: effect on factor VIII:von Willebrand protein as assessed by high-pressure gel permeation chromatography.
    Orthner CL
    J Lab Clin Med; 1984 Nov; 104(5):816-28. PubMed ID: 6436416
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Hemorheologic and coagulation study in a group of patients with diabetic retinopathy].
    Parenti M; Pasquali R; Sorrenti G; Babini AC; Melchionda N; Palareti G; Poggi M; Tricarico G
    G Clin Med; 1984; 65(9-10):409-18. PubMed ID: 6442246
    [No Abstract]   [Full Text] [Related]  

  • 30. Reduced effect of exercise and DDAVP on factor VIII-von Willebrand Factor and plasminogen activator after sequential application of both the stimuli.
    Vicente V; Alberca I; Mannucci PM
    Thromb Haemost; 1984 Feb; 51(1):129-30. PubMed ID: 6426078
    [No Abstract]   [Full Text] [Related]  

  • 31. Acquired von Willebrand syndromes: clinical features, aetiology, pathophysiology, classification and management.
    Michiels JJ; Budde U; van der Planken M; van Vliet HH; Schroyens W; Berneman Z
    Best Pract Res Clin Haematol; 2001 Jun; 14(2):401-36. PubMed ID: 11686107
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influence of factor VIII/von Willebrand complex on the activated protein C-resistance phenotype and on the risk for venous thromboembolism in heterozygous carriers of the factor V Leiden mutation.
    De Mitrio V; Marino R; Scaraggi FA; Di Bari L; Giannoccaro F; Petronelli M; Ranieri P; Tannoia N; Schiraldi O
    Blood Coagul Fibrinolysis; 1999 Oct; 10(7):409-16. PubMed ID: 10695766
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increased factor VIII complex in fulminant hepatic failure.
    Langley PG; Hughes RD; Williams R
    Thromb Haemost; 1985 Oct; 54(3):693-6. PubMed ID: 3937267
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Abnormal plasma levels of factor VIII/von Willebrand factor complex in myocardial infarction--expression of acute phase reaction or index of vascular endothelium damage?
    Giustolisi R; Musso R; Cacciola E; Cacciola RR; Russo M; Petralito A
    Thromb Haemost; 1984 Jul; 51(3):408. PubMed ID: 6437008
    [No Abstract]   [Full Text] [Related]  

  • 35. Factor VIII related antigen, coagulation tests and acute renal failure.
    Sampol J; Robert A; Jahjah F; Gillet A; Olmer M
    Proc Eur Dial Transplant Assoc; 1983; 19():325-8. PubMed ID: 6410377
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Von Willebrand factor/factor VIII concentrates in the treatment of von Willebrand disease.
    Batlle J; López-Fernández MF; Fraga EL; Trillo AR; Pérez-Rodríguez MA
    Blood Coagul Fibrinolysis; 2009 Mar; 20(2):89-100. PubMed ID: 19786936
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dissociation of the Factor-VIII complex during clotting: role of thrombin and phospholipids.
    Muntean W; Rothwangl HJ
    Eur J Clin Invest; 1984 Dec; 14(6):462-8. PubMed ID: 6441724
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Human protein C and thromboembolic disease.
    Gardiner JE; Griffin JH
    Prog Hematol; 1983; 13():265-78. PubMed ID: 6422505
    [No Abstract]   [Full Text] [Related]  

  • 39. Monoclonal antibodies against the human factor VIII von Willebrand molecule: characterization and potential for screening of von Willebrand patients.
    Avner P; Arnaud D; Sultan Y; Maisonneuve P; Jeanneau C
    Dev Biol Stand; 1984; 57():69-76. PubMed ID: 6084622
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increased ristocetin-cofactor in acute myocardial infarction: a component of the acute phase reaction.
    Cucuianu MP; Missits I; Olinic N; Roman S
    Thromb Haemost; 1980 Feb; 43(1):41-4. PubMed ID: 6773172
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.